Amplify Weight Loss Drug & Treatment ETF

Shareclass
Amplify Weight Loss Drug & Treatment ETF (THNR)
Type
Exchange-traded fund
Gender equality score
Gender equality score

57
/ 100 points
Overall score
Average Equileap Gender Equality Score of fund holdings, weighted by market value
Peer rank
Group ranking

A
93.1
percentile

Universe: Groups

Group: Sector Equity

Ranking: 61 out of 864 funds


See more funds from this group
 All funds
 Groups
 Categories
Gender balance in leadership and workforce
Gender balance in leadership and workforce
28/40
See the score criteria
Equal compensation and work life balance
Equal compensation and work life balance
11/30
See the score criteria
Policies promoting gender equality
Policies promoting gender equality
17/20
See the score criteria
Commitment, transparency, and accountability
Commitment, transparency, and accountability
1/10
See the score criteria
Top scoring holdings
Top scoring holdings
The top 10 holdings in this portfolio with the best scores on the Equileap Gender Scorecard. In the case of ties, the holding with more assets invested is listed higher.
  • 1. AstraZeneca PLC ADR
    4.72% of assets
    $136,483 invested
  • 2. Novo Nordisk AS ADR
    14% of assets
    $404,404 invested
  • 3. Merck & Co Inc
    4.02% of assets
    $116,182 invested
  • 4. Roche Holding AG
    4.68% of assets
    $135,085 invested
  • 5. Amgen Inc
    4.57% of assets
    $131,986 invested
  • 6. Thermo Fisher Scientific Inc
    3.97% of assets
    $114,804 invested
  • 7. Teva Pharmaceutical Industries Ltd ADR
    5.05% of assets
    $145,885 invested
  • 8. Pfizer Inc
    4.55% of assets
    $131,356 invested
  • 9. Zealand Pharma AS
    2.29% of assets
    $66,257 invested
  • 10. Eli Lilly and Co
    14% of assets
    $395,391 invested
Bottom scoring holdings
Bottom scoring holdings
The bottom 10 holdings in this portfolio with the worst scores on the Equileap Gender Scorecard. In the case of ties, the holding with more assets invested is listed higher.
  • 1. OPKO Health Inc
    0.22% of assets
    $6,323 invested
  • 2. Viking Therapeutics Inc
    1.52% of assets
    $44,006 invested
  • 3. Mitsubishi Chemical Group Corp
    3.64% of assets
    $105,207 invested
  • 4. Ypsomed Holding AG
    1.2% of assets
    $34,593 invested
  • 5. Chugai Pharmaceutical Co Ltd
    5.64% of assets
    $162,911 invested
  • 6. Bachem Holding AG
    1.33% of assets
    $38,413 invested
  • 7. Hims & Hers Health Inc Ordinary Shares - Class A
    6.89% of assets
    $199,035 invested
  • 8. Gerresheimer AG
    1.66% of assets
    $47,898 invested
  • 9. West Pharmaceutical Services Inc
    4.67% of assets
    $134,944 invested
  • 10. Eli Lilly and Co
    14% of assets
    $395,391 invested
Find sustainably-invested mutual funds and ETFs



Search for funds from your 401(k), retirement plan, or personal portfolio
Financial performance
Performance data provided byMorningstarFind more financial data on THNR at Morningstar.com
Gender Equality and Returns
Returns chart for Amplify Weight Loss Drug & Treatment ETF
Enlarge
The figure above charts annualized returns and Gender Equality Fund grades. The orange marker represents this fund. The purple marker (if present) represents an assigned benchmark. Blue dots represent funds in the same Morningstar category as this fund. Dark gray dots represent funds in the same grading group as this fund. Returns are for the most recent available for this fund of 1, 3, 5, or 10 year annualized returns. The higher a fund is marked on the Y axis, the better its returns for the specified time period. The higher a fund is marked on the X axis, the better its Gender Equality Funds group ranking. Read more on the How it Works page.
Benchmarking tool
Current fund
THNR
Amplify Weight Loss Drug & Treatment ETF
Family
Amplify ETFs
Category
Health
vs.
Benchmark
ACWI
iShares MSCI ACWI ETF
Family
iShares from BlackRock
Category
Global Large-Stock Blend
Fund comparison settings
Investment timeline
Performance as of: 5/31/25
1 year
3 years
5 years
10 years
Benchmark
Suggested: MSCI ACWI
ACWI - iShares MSCI ACWI ETF
Fund comparison results
Compared to the benchmark, this fund has:
Lower 1-yr returns 
24% less  in annualized returns
Higher overall gender equality score 
2 / 100 points higher
Higher gender balance in leadership and workforce score 
2 / 40 points higher
Higher equal compensation and work life balance score 
1 / 30 points higher
Lower policies promoting gender equality score 
1 / 20 points lower
Same commitment, transparency, and accountability score 
0 / 10 points 
Current fund
THNR
Amplify Weight Loss Drug & Treatment ETF
Family
Amplify ETFs
Category
Health
vs.
Benchmark
ACWI
iShares MSCI ACWI ETF
Family
iShares from BlackRock
Category
Global Large-Stock Blend
Fund comparison settings
Investment timeline
Performance as of: 5/31/25
1 year
3 years
5 years
10 years
Benchmark
Suggested: MSCI ACWI
ACWI - iShares MSCI ACWI ETF
Fund comparison results
Compared to the benchmark, this fund has:
Lower 1-yr returns 
24% less  in annualized returns
Higher overall gender equality score 
2 / 100 points higher
Higher gender balance in leadership and workforce score 
2 / 40 points higher
Higher equal compensation and work life balance score 
1 / 30 points higher
Lower policies promoting gender equality score 
1 / 20 points lower
Same commitment, transparency, and accountability score 
0 / 10 points 
Current fund
THNR
Amplify Weight Loss Drug & Treatment ETF
Family
Amplify ETFs
Category
Health
vs.
Benchmark
ACWI
iShares MSCI ACWI ETF
Family
iShares from BlackRock
Category
Global Large-Stock Blend
Fund comparison settings
Investment timeline
Performance as of: 5/31/25
1 year
3 years
5 years
10 years
Benchmark
Suggested: MSCI ACWI
ACWI - iShares MSCI ACWI ETF
Fund comparison results
Compared to the benchmark, this fund has:
Lower 1-yr returns 
24% less  in annualized returns
Higher overall gender equality score 
2 / 100 points higher
Higher gender balance in leadership and workforce score 
2 / 40 points higher
Higher equal compensation and work life balance score 
1 / 30 points higher
Lower policies promoting gender equality score 
1 / 20 points lower
Same commitment, transparency, and accountability score 
0 / 10 points 
Month-end trailing returns  
Annualized returns
Gender-lens analysis
1-yr
3-yr
5-yr
10-yr
Overall gender equality score
This fund
THNR - Amplify Weight Loss Drug & Treatment ETF
-10.64%
/
/
/
57  / 100 points
Benchmark
ACWI - iShares MSCI ACWI ETF
14%
12%
13%
9.39%
55  / 100 points
Fund compared to benchmark
 
-24.14%
/
/
/
2  / 100 points higher
Find more financial data on THNR at Morningstar.com
What's next?
Learn how to make a change and move your money
Get started with our action toolkit
Ask your employer about gender-lens investing in your retirement plan
Find socially responsible funds that invest in gender equality
Learn more about As You Sow's Invest Your Values program
Visit Fossil Free Funds to measure the climate risk of this portfolio
More from Invest Your Values
See how mutual funds and ETFs are rated on issues ranging from fossil fuels, to deforestation, gender equality, guns, prisons, weapons, and tobacco

Disclaimer: As You Sow is not an investment adviser

As You Sow is not an investment adviser as that term is defined under federal and state (California) laws and regulations. As You Sow is a tax-exempt, nonprofit organization dedicated to educating and empowering shareholders to change corporations for the good through the collection, analysis and dissemination of relevant information to the public, free of charge. As You Sow does not provide financial planning, legal or tax advice. Nothing on this website shall constitute or be construed as an offering of financial instruments, or as investment advice or investment recommendations.
See our full disclaimer